Vuong Trieu
Vuong Trieu has made 1 open-market purchase worth $24k since Oct 30, 2026, in 1 company. The latest: $24k of OTLC, filed Oct 30, 2026, scored 26 out of 100.
Chair, Oncotelic Therapeutics, Inc.
Follow Vuong Trieu, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 30 Form 4 (opens sec.gov) |
OTLCOncotelic Therapeutics, Inc. · ChairChair · Penny stock: hard to trade | +2% stake | 26 | $24k 1,356,990 at $0.02 |
— | — |
Questions
What stock has Vuong Trieu bought?
OTLC (Oncotelic Therapeutics, Inc.), all on the open market and reported on SEC Form 4.
When did Vuong Trieu last buy?
Oct 30, 2026: 1,356,990 shares of OTLC at $0.02, $24k in all (Form 4 (opens sec.gov)).
Has Vuong Trieu filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Vuong Trieu a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer